JPS6158582A - Continuous circulation cell culture apparatus - Google Patents

Continuous circulation cell culture apparatus

Info

Publication number
JPS6158582A
JPS6158582A JP17851284A JP17851284A JPS6158582A JP S6158582 A JPS6158582 A JP S6158582A JP 17851284 A JP17851284 A JP 17851284A JP 17851284 A JP17851284 A JP 17851284A JP S6158582 A JPS6158582 A JP S6158582A
Authority
JP
Japan
Prior art keywords
culture
oxygen
culture liquid
tank
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17851284A
Other languages
Japanese (ja)
Inventor
Katsutoshi Yoshizato
勝利 吉里
Shinichiro Kusunoki
楠 慎一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance Res & Dev Co Ltd
Original Assignee
Advance Res & Dev Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Res & Dev Co Ltd filed Critical Advance Res & Dev Co Ltd
Priority to JP17851284A priority Critical patent/JPS6158582A/en
Publication of JPS6158582A publication Critical patent/JPS6158582A/en
Pending legal-status Critical Current

Links

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

PURPOSE:To carry out the efficient culture of cerebral cells, etc. in the state of high dissolved oxygen content, preventing the foaming to the culture liquid, by absorbing oxygen to culture liquid in a pressure chamber, and circulating the oxygen-containing culture liquid to the culture tank. CONSTITUTION:A pressure chamber 3 to add oxygen to a culture liquid under high pressure is attached to a culture chamber 2, and culture liquid is circulated with a circulation pump 4 through the circulation line 6. The solenoid valves 13 and 14 are in open state in the circulation of the culture liquid. When the dissolved oxygen content of the culture liquid is decreased below a specific level, the controlling apparatus 10 operated by the signal transmitted from the sensor units 8 and 9 detecting the oxygen content, the leak valve 12 and the solenoid valves 13, 14 are closed, and the valve 11 is opened to supply oxygen from the tank 5 to the pressure chamber 3. The supplied oxygen is dissolved in the culture liquid under the pressure of about 2-5atm. After the absorption of oxygen, the leak valve 12 is opened to return the pressure chamber to atmospheric pressure, and the solenoid valves 13 and 14 are opened to start the circulation of the culture liquid having high dissolved oxygen content while removing the bubbles with the filter 15.

Description

【発明の詳細な説明】 本発明は動物の各種細胞の培養のための連続還流培養装
置〆1に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a continuous perfusion culture device 1 for culturing various animal cells.

脳細胞や肝実質細胞等の特殊な細胞は低酸素濃度の培養
条1′1では細胞数の極端な減少及び機能低下がみられ
る。jffl常の培!f装置nの培養液の溶存酸素濃度
は、およそ1〜3ppmに限られていた。
Special cells such as brain cells and hepatic parenchymal cells show an extreme decrease in cell number and functional decline in culture column 1'1 with a low oxygen concentration. jffl common cultivation! The dissolved oxygen concentration of the culture solution in device f was limited to approximately 1 to 3 ppm.

しめ化前述の動物細胞の培養においては上り高い溶存酸
素濃度で効果の高いことが明らかにされてきている。従
来、溶存酸素濃度を高める方法として常圧下で酸素又は
空気を培養液中にバブリングする方法が提案されていた
。この場合、溶存酸素濃度はかなり;ン 向くなるが、培養液にホーミングが生しる欠点を有して
いた。こいう。前者の泡の原因は培養液の血清中等に含
まれているたんばく質の変性によって生したものである
ため、細胞を培養するときの障害となる。後者の気泡は
バブリングの際、酸素が溶解しきらずに残0?シたもの
で、溶存酸素濃度等をセンサすることが不可能となるた
めデータの把握や濃度等のフントロール等がで外なくな
ってしよう欠点を有していた。従ってバブリングによる
溶存酸素濃度を高める方法は動物細胞を培養するとき、
特に人工臓器としてこのシステムを利用する場合、極め
て重大な欠点を有するものであった。
It has been revealed that moistening is highly effective in culturing the aforementioned animal cells at higher dissolved oxygen concentrations. Conventionally, a method of bubbling oxygen or air into a culture solution under normal pressure has been proposed as a method for increasing the dissolved oxygen concentration. In this case, the dissolved oxygen concentration is considerably improved, but it has the disadvantage that homing occurs in the culture solution. like this. The former bubbles are caused by the denaturation of proteins contained in serum, etc. of the culture solution, and are an obstacle when culturing cells. In the latter case, during bubbling, oxygen is not completely dissolved and 0 remains. However, since it is impossible to measure the dissolved oxygen concentration, etc., it is difficult to grasp the data and monitor the concentration. Therefore, when culturing animal cells, the method of increasing dissolved oxygen concentration by bubbling is
Particularly when this system is used as an artificial organ, it has extremely serious drawbacks.

]1記に鑑み本発明者らは、鋭意研究の結果、溶存酸素
濃度を高めるための加圧室を培養装置に導入し、この加
圧室に酸素を充填して加圧(2〜5a1.+n)するこ
とにより、培養液に酸素は良好に溶解され、またこの高
濃度酸素を含む加圧培養液は、常圧に減圧後も培養液の
溶存酸素濃度を充分高く保てること、さらにこの方法で
はホーミングは培養液中にわずかに気泡を生じるだけで
この気泡もフィルター等で容易に取り除けることを知見
し、本発明に到達したものである。
] In view of the above, as a result of intensive research, the present inventors introduced a pressurization chamber to increase the dissolved oxygen concentration into the culture apparatus, filled this pressurization chamber with oxygen, and pressurized it (2 to 5a1. +n), oxygen is well dissolved in the culture medium, and this pressurized culture medium containing high oxygen concentration can maintain a sufficiently high dissolved oxygen concentration in the culture medium even after the pressure is reduced to normal pressure. The present invention was developed based on the discovery that homing produces only a small amount of air bubbles in the culture solution and these air bubbles can be easily removed using a filter or the like.

以下、本発明の第1の実施例を図面第1図を参照して、
詳細に前記培養槽(2)は、被培養細胞の担体として中
空糸及び/又はフ(8)(9)は被培養細胞特に実質細
胞の機能維持状態をだしかめるために、培養液の温度、
pi−1、溶存酸素濃度、炭酸ガス濃度、グルツース濃
度、等を計測するための各種センサが内設されている。
Hereinafter, a first embodiment of the present invention will be described with reference to FIG.
In detail, the culture tank (2) uses hollow fibers and/or fibers (8) and (9) as carriers for the cultured cells in order to maintain the function of the cultured cells, especially the parenchymal cells, at a temperature of the culture solution.
Various sensors for measuring pi-1, dissolved oxygen concentration, carbon dioxide concentration, gluten concentration, etc. are installed inside.

このセンサユニッ)(8Mり)は コン10−ルユニツ
) (10)に接続され、この培養装置の各機描を制御
するように構成されている。
This sensor unit (8M) is connected to the controller (10) and is configured to control each device of this culture device.

(5)は酸素タンクである。この酸素タンク(5)は、
加圧室(3)に連絡管(7)により接続さねている。ま
た前記連絡管(7)と加圧室(3)との接続点には電気
的に制御される開閉バルブ(11)が設けられており、
この開閉バルブ(11)は前記フン10−ルユニツト(
10)に接続されでいる。(12)はリークバルブ、(
+:1)(+4)は電磁弁でそれらの開閉制御は全てコ
ン)・ロールユニッ)(In)に]二1)行われる。。
(5) is an oxygen tank. This oxygen tank (5) is
It is connected to the pressurizing chamber (3) by a connecting pipe (7). Furthermore, an electrically controlled opening/closing valve (11) is provided at the connection point between the communication pipe (7) and the pressurizing chamber (3),
This opening/closing valve (11) is connected to the fan 10-le unit (
10). (12) is a leak valve, (
+:1)(+4) are solenoid valves, and their opening/closing control is all performed by the control/roll unit) (In)]21). .

(16)はスターラーバーで加圧室(3)の1ζ部に配
置されたスターク−(図示せず)により回転L−)−:
j M液を攪拌するために加圧室11(而に載置されて
いる。(15)は気泡除去用フィルターで例えばミリポ
アフィルタ−で構成され、培養液がこのフィルター(1
5)を通過することにより気泡を除去した培養液を培養
槽(2)に供給するために設けられたものである。
(16) is a stirrer bar which is rotated by a stirrer (not shown) placed in the 1ζ section of the pressurizing chamber (3) L-):
j In order to stir the M solution, the pressurizing chamber 11 (which is placed in
5) to supply the culture solution from which air bubbles have been removed to the culture tank (2).

次に−1−記のように構成しrこ本発明連続還流細胞培
養装置の作用の溶存酸素濃度が低くなったと外センサユ
ニッ)(8H9)が感知り、酸素タンク(5)から加圧
室(3)に酸素が充填され加圧室内は2〜5a1.m程
度に加圧される。次にスターラーバー(16)を回転さ
せる。この動作により培養液の」二面より酸素は培養液
中に溶解する。充分酸素を溶解させた後、開閉バルブ(
11)を閉塞し、リークバルブ(12)を開と加圧室内
の圧を常圧に減圧する。減圧後、電磁弁(+3)(+4
)を開き再び培養液を培養槽(2)へ連続的に還流させ
る。
Next, the external sensor unit (8H9) senses that the dissolved oxygen concentration of the continuous perfusion cell culture device of the present invention has become low, and the oxygen tank (5) is transferred from the pressurized chamber ( 3) is filled with oxygen and the inside of the pressurized chamber is 2-5a1. It is pressurized to about m. Next, rotate the stirrer bar (16). This action causes oxygen to dissolve into the culture solution from both sides of the culture solution. After dissolving enough oxygen, open and close the valve (
11) and open the leak valve (12) to reduce the pressure in the pressurized chamber to normal pressure. After pressure reduction, solenoid valve (+3) (+4
) is opened and the culture solution is continuously refluxed into the culture tank (2) again.

このどき加圧室内に発生した気泡はわずかであるため気
泡除去フィルター(15)によって除去される。
Since the bubbles generated in the pressurized chamber at this time are few, they are removed by the bubble removal filter (15).

次に本発明連続還流細胞培養装置の第2の実施例を図面
第2図−:(− を参照して詳細に説明するか、前記第1の実施例と同一
部分には同一符号をイ・1し、その説明を省略する。(
+7)(+8)はプランツヤ−ポンプである。(19)
はりサーバータンク、(20)はプレタンクである。プ
ランジャーポンプ(17)は加圧室(3)の培養液をリ
ザーバータンク(+9)へ送るため、ブランン゛ヤーボ
ンブ(18)l土ブレタンク(20)の培養液を加圧室
(3)・\送るために設けられlこ(代構であり、各々
コン10−ルユニツ1.(10)に接続されている。
Next, a second embodiment of the continuous perfusion cell culture apparatus of the present invention will be described in detail with reference to FIG. 1, and its explanation will be omitted. (
+7) (+8) is a planter pump. (19)
The beam server tank (20) is a pre-tank. The plunger pump (17) sends the culture solution in the pressurized chamber (3) to the reservoir tank (+9), so the plunger pump (17) sends the culture solution in the tank (20) to the pressurized chamber (3). 1 (alternative structure), each of which is connected to a controller 10 (10).

本実施例の作用はプレタンク(20)、リザーバータン
ク(+!1)Thq・にシステムは第1の実施例と同様
であるか、還流ポンプ(4)は常に作動し、電磁弁(1
3)(14)が閉塞している間はりサーバータンク(1
9)に貯蔵された培養液を培養槽(2)へ供給する。そ
して溶存酸素濃度が所定値となった時、プランジャ−ポ
ンプ(+7)(18)は作動を開始し、還流すると共に
リザーバータンク(19)にも貯蔵用の培養液が供給さ
れる。
The operation of this embodiment is the same as that of the first embodiment, in which the pre-tank (20), the reservoir tank (+!1), and the system are the same as those of the first embodiment.
3) While (14) is blocked, the beam server tank (1
The culture solution stored in 9) is supplied to the culture tank (2). When the dissolved oxygen concentration reaches a predetermined value, the plunger pumps (+7) (18) start operating, causing reflux and supplying the culture solution to the reservoir tank (19) as well.

次に本発明連続還流細胞培養装置の加圧室の他の実施例
を図面第3図を参照して詳細に説明するが、前記第1の
実施例と同一部分には同一符号をイ・1した。(21)
は中空糸であり、酸素タンク(5)=4− に接続された連絡管(7)に連結されている。この中空
糸(21)の先端は閉塞されている。尚、中空糸の代わ
りにテフロン管やボアテックスチューブ等も使用しうる
Next, another embodiment of the pressurizing chamber of the continuous perfusion cell culture device of the present invention will be described in detail with reference to FIG. did. (21)
is a hollow fiber and is connected to a communication pipe (7) connected to an oxygen tank (5) = 4-. The tips of the hollow fibers (21) are closed. Note that a Teflon tube, a Boretex tube, etc. can also be used instead of the hollow fiber.

−1−記加圧室の作用を説明する。培養液の溶存酸素濃
度が低くなりた時、フン10−ルユニツト(10)の制
御によりリークバルブ(12)電磁弁(13)(+4)
が閉塞し、開閉バルブ(11)が間外酸素が中空糸(2
1)を通って加圧室(3)に充填される。その結果、酸
素は中空糸内から溶は出し培養液中に溶解される。同時
に加圧室内も加圧される。そのため培養液の−に面から
も溶解は進行する。この作用中、)スターラーバ−(1
6)も回転する。充分酸素を溶解した後の減圧、◇・ 還流の作用は第1の実施例と同様であるため、その説明
を省略する。
-1- The operation of the pressurizing chamber will be explained. When the dissolved oxygen concentration of the culture medium becomes low, the leak valve (12), solenoid valve (13) (+4) is activated by the control of the fan unit (10).
When the opening/closing valve (11) is closed, the external oxygen is removed from the hollow fiber (2).
1) and is filled into the pressurized chamber (3). As a result, oxygen is dissolved out from within the hollow fibers and dissolved in the culture solution. At the same time, the pressurizing chamber is also pressurized. Therefore, dissolution proceeds also from the negative side of the culture solution. During this action, the stirrer bar (1
6) also rotates. The actions of reducing the pressure and ◇・refluxing after sufficiently dissolving oxygen are the same as in the first embodiment, so their explanation will be omitted.

とるように構成するのが好ましい。It is preferable to configure it so that it takes

また、本発明装置は、各臓器細胞を培養し、代用人工臓
器に応用できる。この際の特徴として培養液の溶存酸素
濃度を高く保つ二と以外に、培養槽内の中空糸の外側に
実質細胞と、コラーゲン。
Furthermore, the device of the present invention can be applied to culturing cells of various organs and producing substitute artificial organs. In addition to maintaining a high dissolved oxygen concentration in the culture medium, the characteristics of this case include parenchymal cells and collagen on the outside of the hollow fibers in the culture tank.

糖タンパク質等の細胞外マトリックスと、線it芽細胞
等の非実質細胞とを共存させ本来の臓器機能を長期間代
用させうる点と、中空糸ユニットの前に血液中の血球成
分と血漿成分を分離するユニ・ントを有する点があげ゛
られる。
Extracellular matrices such as glycoproteins and non-parenchymal cells such as cytoblasts coexist, allowing the original organ functions to be substituted for a long period of time. The point is that it has a unit that separates.

以−1〕の説明上り明らかなように、本発明連続還流細
胞培養装置によれば、培養液の溶存酸素濃度の高い被培
養細胞に好適な条件性細胞、腎実質細胞、肝実質細胞等
の実質細胞に適用17た場合にバータンク(19)の作
用により常に一定室、の培養液を間断無く培養槽に流す
ことが可能となる。さらに実用的な而からもリザーバー
タンク中へ、血液、血清等を加える5−とかでとるのも
利点である。
As is clear from the explanation in (1) below, the continuous perfusion cell culture device of the present invention allows the cultivation of facultative cells, renal parenchymal cells, hepatic parenchymal cells, etc., which are suitable for cultured cells with a high dissolved oxygen concentration in the culture medium. When applied to parenchymal cells, the action of the bar tank (19) makes it possible to constantly flow the culture solution in a certain chamber into the culture tank without interruption. Furthermore, from a practical standpoint, it is advantageous to add blood, serum, etc. to the reservoir tank.

また、加圧室の他の実施例においては、酸素と培養液と
の接触する面積が広いすなわち中空糸の全ての表面より
酸素が溶解するため、溶解速度が速く、消費する酸素量
も少■で充分な効果がj(1られる。
In addition, in other embodiments of the pressurized chamber, the contact area between oxygen and the culture medium is large, that is, oxygen is dissolved from all surfaces of the hollow fibers, so the dissolution rate is fast and the amount of oxygen consumed is small. The sufficient effect is j(1).

次に本発明連続還流細胞培養装置を利用した肝実質細胞
の培養における酸素の影響と代用人工臓器への応用の実
験例について説明する。
Next, an experimental example of the influence of oxygen in culturing hepatic parenchymal cells using the continuous perfusion cell culture device of the present invention and its application to a substitute artificial organ will be explained.

実験例1− 肝実質細胞培養における酸素の影響 i、IIF1Mからの実質細胞の分離及び培養ゲナーゼ
 Typelを細胞分散用(和光純薬製)、仔牛血清を
牛胎児血清(GTBCO製)に変更し、培地をDE(日
永製薬製)、RPMT  164.(1((響IBCO
製)を追加した以外は通常のコラゲナーゼ還流法で行な
った。(中村ら 別間蛋白質核酸酵素No、24 19
I31) 2、培養槽中気相成分の違いによる培養肝実質細胞をプ
1/−Fにでインキュベーター中で気相成分としてC,
02を5%に固定17.02とN2比を変化させて、通
常の方法で培養を行なった。(中村ら 別間蛋白質核酸
酵素No、241’981)  そして培養後のプレー
トへの肝実質細胞の接着率及び肝実質細胞の培養経過口
数における生存率を求めた。接着     □率に関し
ては培養後10経過したプレートをHira!、aらの
方法(Gann  I 984. )に従いトルイジン
ブルー染色により求めた。
Experimental Example 1 - Effect of oxygen on hepatic parenchymal cell culture i, Isolation of parenchymal cells from IIF1M and culture Genase Type was changed to cell dispersion (manufactured by Wako Pure Chemical Industries, Ltd.), calf serum was changed to fetal bovine serum (manufactured by GTBCO), The culture medium was DE (manufactured by Hinaga Pharmaceutical Co., Ltd.) and RPMT 164. (1((Hibiki IBCO
The conventional collagenase reflux method was used except for the addition of (manufactured by Manufacturer Co., Ltd.). (Nakamura et al. Betsuma Protein Nucleic Acid Enzyme No. 24 19
I31) 2. Cultured liver parenchymal cells due to differences in gas phase components in the culture tank were heated to 1/-F in an incubator with C, C, and C as gas phase components.
Culture was carried out in a conventional manner by fixing 02 to 5% and changing the N2 ratio to 17.02. (Nakamura et al. Betsuma Protein Nucleic Acid Enzyme No. 241'981) Then, the adhesion rate of hepatic parenchymal cells to the plate after culture and the survival rate of hepatic parenchymal cells based on the number of culture ports were determined. Regarding the adhesion □ rate, use the Hira! plate after 10 years of culture. It was determined by toluidine blue staining according to the method of , et al. (Gann I 984.).

生存率に関しては培養プレートからトリプシン処理によ
り細胞をはがしトリパンブルー処理し染色されない細胞
数から求めた。
The survival rate was determined from the number of cells that were removed from the culture plate by trypsin treatment, treated with trypan blue, and not stained.

その結果を第4図及び第5図に示した。第4図は肝実質
細胞のプレートへの接着率を示したもので縦軸は接着率
(%)、横軸は培養槽中の気相の酸素の濃度(%)であ
る。第5図は生存率を示し、縦軸は肝実質細胞の生存率
(%)横軸は培養後の時間(B)グラフ1,2,3,4
はそれぞれ培養槽中の気相の酸素の濃度が0.20,5
0.70(%)の条件でのグラフである。
The results are shown in FIGS. 4 and 5. FIG. 4 shows the adhesion rate of hepatic parenchymal cells to the plate, where the vertical axis is the adhesion rate (%) and the horizontal axis is the concentration of oxygen in the gas phase in the culture tank (%). Figure 5 shows the survival rate, the vertical axis is the survival rate (%) of hepatic parenchymal cells, and the horizontal axis is the time after culture (B).Graphs 1, 2, 3, 4
The concentration of oxygen in the gas phase in the culture tank is 0.20 and 5, respectively.
This is a graph under the condition of 0.70(%).

3、培養液中溶存酸素濃度の変化に伴う生存率前述1で
分離・培養した肝実質細胞を本発明連続還流細胞装置の
培養槽部分に(1,5−1、OX、10”cells/
cm2となるように接着させたシャーレを入れ、培養液
中溶存酸素濃度を変化させ生存率を調べた。生存率は前
記2と同様の方法で測定した。
3. Survival rate associated with changes in dissolved oxygen concentration in the culture solution The hepatocytes separated and cultured in 1 above were placed in the culture tank part of the continuous perfusion cell device of the present invention (1,5-1, OX, 10” cells/
A petri dish was placed in which the cells were adhered to a size of cm2, and the survival rate was examined by varying the concentration of dissolved oxygen in the culture solution. The survival rate was measured in the same manner as in 2 above.

さらにアルブミン量は細胞をソニーケータ−で充分に破
壊してBCG法で、またGOT活性は同様の方法で得た
分画と培養液1とをpop法で測定した。
Further, the amount of albumin was measured by the BCG method after sufficiently disrupting the cells with a sonicater, and the GOT activity was measured by the POP method using a fraction obtained in the same manner and culture solution 1.

その結果を第6図に示した。図中縦軸は生存率(%)、
横軸は培養後の時間(日)でグラフ1,2.3,4.S
、6は培養液中の溶存酸素濃度が0.1.2,5.’L
  10,15(ppm)の条件下でのグラフである。
The results are shown in FIG. The vertical axis in the figure is the survival rate (%),
The horizontal axis represents the time (days) after culture in graphs 1, 2.3, 4. S
, 6, the dissolved oxygen concentration in the culture solution is 0.1.2, 5. 'L
It is a graph under the condition of 10.15 (ppm).

=8− 4、結 果 紹織培養の条件として長い間5%CO2,9S%air
が用いられてきたが生体内の#ll胞はその存在する環
境に大きな違いがあるのと同時に、細胞によって異なっ
た(幾能を担っている。今までにも全ての細胞が」〕述
の条件を最適とせず、例えば線Mt芽細胞ではかなり低
い酸素濃度条件下でよく生育することが、また、定性的
な報告が成されている。今回性なった酸素量による結果
は、第4図、第5図に示す」:つに培養槽中気相酸素濃
度が通常の培養条件(20%02)より高い50%02
でプレートへの接着率及び生存率共に最も高く、70%
02以」二ではその効果がやや減少した。一方、肝山米
の線紺芽細胞は低酸素状態でのみ生存する等、酸素に対
する要求性は全ての細胞で画一的でなく組ので培養液中
ヘカタラーゼ、スパーオキシドディスムターゼ、ラジカ
ルスキャベンジャ−あるいは−重項酸素のクエンチャ−
であると考えられるビタミンE(Ct−tocopl+
erol)+ N−pro−pylgal lat、e
(以」I S i grna製)を添加することで高酸
素状態での肝実費細胞と111山来綿矧」細胞の生存率
・\の効果を調べたど、−ろ、特に70%02以1−で
その効」5が−4しかった。
= 8-4, Results: 5% CO2, 9S% air for a long time as conditions for culture.
However, the #ll cells in living organisms differ greatly in the environment in which they exist, and at the same time, they also differ depending on the cell. It has also been qualitatively reported that, without optimizing the conditions, for example, Mtblast cells grow well under considerably low oxygen concentration conditions.The results of this new oxygen amount are shown in Figure 4. , as shown in Figure 5: 50%02 where the gas phase oxygen concentration in the culture tank is higher than the normal culture conditions (20%02)
The adhesion rate to the plate and the survival rate are the highest at 70%.
After 02, the effect decreased slightly. On the other hand, all cells do not have the same requirement for oxygen, such as the cyanoblast cells of Kinzan rice, which survive only in hypoxic conditions. -Quencher of heavyt oxygen-
Vitamin E (Ct-tocopl+
erol) + N-pro-pylgal lat, e
We investigated the effect on the survival rate of liver cells and 111 Yamaki Cotton Hagi cells under hyperoxic conditions by adding ISI grna. The effect was 1- and 5 was -4.

第4図及び第5図から、肝実質細胞の培養条flは通常
の酸素;量では低すぎることか明らかになった。さらに
、第6図に示す1(’  ! 層ように、本発明連続還流細胞培養装置により溶存酸素
濃度を1):確にコントロールして行なった実験から肝
実質細胞の培養には培養液中の酸素濃度5〜15ppm
が細胞の生存には必要で7・−・10 ppmが最適で
あった。肝機能M[持にも著しい効果を示し、アルブミ
ン合成量は酸素2 ppmでは、培養後7日で培養開始
時の5〜10%に低下するにもかかわらず、7〜1(l
ppmでは80%以」二の値を示した。又、細胞のG 
OTは7〜10pl−1mではほぼ100%に相持され
るが2ρ1111+では10〜20%まで低下する。培
養液中のG OTは7−10 ppmでは2 ppmに
比べて著しく低い値を示した。
From FIGS. 4 and 5, it is clear that the culture condition fl of hepatic parenchymal cells is too low with normal oxygen levels. Furthermore, as shown in Figure 6, the continuous perfusion cell culture device of the present invention has been used to precisely control the dissolved oxygen concentration to 1 (as shown in Figure 6). Oxygen concentration 5-15ppm
was necessary for cell survival, and 7-10 ppm was optimal. It also showed a remarkable effect on liver function M [2 ppm oxygen], although albumin synthesis decreased to 5-10% of the initial level after 7 days of culture.
In terms of ppm, it showed a value of 80% or more. Also, the G of the cell
OT is maintained at almost 100% at 7-10 pl-1 m, but decreases to 10-20% at 2ρ1111+. GOT in the culture solution showed a significantly lower value at 7-10 ppm than at 2 ppm.

因子の機能を失うことなく、マイルドに培養液中の溶存
酸素濃度を」1昇させることを可能にした。
This made it possible to mildly increase the dissolved oxygen concentration in the culture solution by 1" without losing the function of the factor.

寒験例裟 代用人工肝臓システムへの応用 1、肝臓からの実質細胞の分離及び培養実験例1と同様
に行なった。
The experiment was carried out in the same manner as in Example 1 of the Cold Experiment: Application to a Substitute Artificial Liver System, Isolation and Cultivation of Parenchymal Cells from the Liver.

2、IIFl愚からの線!+1芽細胞の分離た線維芽細
胞の初代培養細胞を用いた。
2. A line from IIFl foolishness! A primary culture of fibroblasts isolated from +1 blast cells was used.

3、モデル臓器デルの調製 Ty+telコラーゲン(高研、牛皮7由来 アテロコ
ラーゲン)を0.2%となるようにpl+3の塩酸又は
酢酸溶液に溶解する。
3. Preparation of model organ model Ty+tel collagen (Koken, atelocollagen derived from cowhide 7) is dissolved in a pl+3 hydrochloric acid or acetic acid solution to a concentration of 0.2%.

充分攪拌後、高濃度のリン酸bt+f fer(pH7
、4)又は10倍濃度の細胞培養用培養液にて中性にす
る。4°Cに保ったコラーデン溶液中にTypeJ、■
コラーゲン(BRL、ヘキストジ+ハン)。
After thorough stirring, add highly concentrated phosphoric acid bt+f fer (pH 7
, 4) or neutralize with a 10-fold concentrated cell culture medium. Type J, ■ in the colladen solution kept at 4 °C.
Collagen (BRL, Hoechstji + Han).

フィブロネクチン(Sigtna製)、ラミニン(7ナ
コシ製)等の細胞外7トリツクス成分を0.01〜0.
0(101%になるように加え、ゆっくり攪拌する。又
、細胞外マトリックスを羊膜(SDプラット上り粗抽出
した成分を使用した方が細胞の静着及び機能tf、持等
の面ですぐれていた。次にこの溶液に肝実質細胞、線維
芽細胞を混合し、全体を均一にする。この液を手早く、
中空糸の外側に満たし、37℃の恒温水槽中に水溶し、
10分程度でゲル化させる。次に手早く10%FBSを
含むDE培養液を−I+− 中空糸中に満たし細胞培養を開始する。
Extracellular 7 Trix components such as fibronectin (manufactured by Sigtna) and laminin (manufactured by 7 Nakoshi) were added at 0.01-0.
0 (101%) and stir slowly.Also, use amniotic membrane as the extracellular matrix (SD platform crudely extracted components were better in terms of cell adhesion and functional TF, retention, etc.). Next, mix hepatic parenchymal cells and fibroblasts with this solution and make it homogeneous.
Fill the outside of the hollow fiber and dissolve in water in a constant temperature water bath at 37°C.
It will gel in about 10 minutes. Next, DE culture solution containing 10% FBS is quickly filled into the -I+- hollow fiber to start cell culture.

又、もう1つの方法としては中空糸の外側を0,2%T
yr+elコラーデン、(1,(11−0,0001%
T ype IV t V :7ラーデン、フィブロネ
クチン、ラミニン溶液を37℃でゲル化後、凍結乾燥し
て多孔質基質をイ)1てγ線又はUVで架橋したフラー
デンスポンジに肝実質細胞及び線紺芽細胞を靜着させた
ゲルで満たして培養を開始する。
Another method is to coat the outside of the hollow fiber with 0.2% T.
yr + el colladen, (1, (11 - 0,0001%
Type IV t V: 7 After gelling a solution of laden, fibronectin, and laminin at 37°C, lyophilize it to form a porous matrix. Culture is started by filling the gel with the germ cells.

4、培養条件 培養には第1図に示す連続還流細胞培養装置を用いる。4.Culture conditions For culturing, a continuous perfusion cell culture apparatus shown in FIG. 1 is used.

この際、培養液の)開度は37±0.2℃、培養液還流
速度0 、3 mN/中空糸の外側の細胞特に実質細胞
は高酸素濃度レベルの培養でよく生存した。また、無血
清培地DM(R,Enat、  el、  at。
At this time, the opening degree of the culture solution was 37±0.2° C., and the culture solution reflux rate was 0.3 mN/cells outside the hollow fiber, especially parenchymal cells, survived well in the culture at a high oxygen concentration level. In addition, serum-free medium DM (R, Enat, el, at.

Proc、 Na1.1. /\cad、 S c、 
i、\’o1.811’lil  ’84)での増殖は
血清存在の培地に比べ著しくすぐれていた。又、肝槻能
の発現は血清を含む通常の培地にもどした時の)jがす
ぐれていた。
Proc, Na1.1. /\cad, S c,
i, \'o1.811'lil '84) was significantly superior to the serum-containing medium. In addition, the expression of hepatic ability was excellent when the cells were returned to a normal medium containing serum).

さらに全肝臓摘出ラットに1述の中空糸を糾み込んだシ
スチー12= ムを用いたところ数日間生存した。細胞の血清に対する
適応の目的で還流液を100%血清に近づけるまで20
%、50%血清で1日づつ培養したところゲル中の細胞
の生存率及び機能発現は良好で内情濃度変化の適応を考
えに入れれば、充分に代用人工臓器として使用可能であ
る。
Furthermore, when the System 12 system containing the hollow fibers described above was used in rats whose whole liver had been removed, they survived for several days. 20 minutes until the perfusion solution approaches 100% serum for the purpose of cell adaptation to serum.
% and 50% serum for one day each, the survival rate and functional expression of the cells in the gel were good, and if the adaptation to internal concentration changes is taken into account, it can be used as a substitute artificial organ.

【図面の簡単な説明】[Brief explanation of the drawing]

第1l:本発明の第1の実施例を示す一部断面図第2図
:本発明の第2の実施例を示す一部断面図第3図:本発
明の加圧室の他の実施例を示す要部断面図第4図二本発
明の実験例における肝実質細胞のプレートへの接着率(
%)と培養槽気相中の酸素(%)とのグラフ第5図、第
6N:本発明の実験例における肝実質細胞の生存率(%
)と培養後の時間(日)とのグラフ(1)・・・連続還
流培養装置、(2)・・・培養槽。 (3)・・・加圧室、 (4)・・・還流ポンプ。 (5)・・・酸素タンク、(6)・・・還流パイプ。 特許出願人  株式会社アドバンス開発研究所醜育、1
&ル (%) 1に5図 培養後、 B%簡 (8) 第6図
Part 1l: Partial sectional view showing the first embodiment of the present invention. Fig. 2: Partial sectional view showing the second embodiment of the invention. Fig. 3: Other embodiments of the pressurizing chamber of the present invention. Figure 4 is a sectional view of the main part showing the adhesion rate of hepatic parenchymal cells to the plate in the experimental example of the present invention (
%) and oxygen in the gas phase of the culture tank (%) Figures 5 and 6N: Viability rate (%) of hepatic parenchymal cells in experimental examples of the present invention
) and the time (days) after culture (1) Continuous reflux culture device, (2) Culture tank. (3)...pressure chamber, (4)...reflux pump. (5)...Oxygen tank, (6)...Recirculation pipe. Patent Applicant: Advance Development Research Institute, Inc., 1
&le (%) Figure 1 to 5 After culture, B% simple (8) Figure 6

Claims (1)

【特許請求の範囲】[Claims] (1)培養槽へ供給される培養液の溶存酸素を常に高濃
度に保つために、加圧室と、この加圧室に接続された酸
素タンクと、培養槽と、さらに培養液を培養槽と加圧室
とに還流させるための還流パイプと、還流ポンプとを備
えたことを特徴とする連続還流細胞培養装置。
(1) In order to always maintain a high concentration of dissolved oxygen in the culture solution supplied to the culture tank, there is a pressurized chamber, an oxygen tank connected to this pressurized chamber, a culture tank, and a culture tank in which the culture solution is supplied to the culture tank. 1. A continuous reflux cell culture device comprising: a reflux pipe for refluxing the blood to the pressurized chamber; and a reflux pump.
JP17851284A 1984-08-29 1984-08-29 Continuous circulation cell culture apparatus Pending JPS6158582A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17851284A JPS6158582A (en) 1984-08-29 1984-08-29 Continuous circulation cell culture apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17851284A JPS6158582A (en) 1984-08-29 1984-08-29 Continuous circulation cell culture apparatus

Publications (1)

Publication Number Publication Date
JPS6158582A true JPS6158582A (en) 1986-03-25

Family

ID=16049766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17851284A Pending JPS6158582A (en) 1984-08-29 1984-08-29 Continuous circulation cell culture apparatus

Country Status (1)

Country Link
JP (1) JPS6158582A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63226204A (en) * 1987-03-17 1988-09-20 海洋科学技術センタ− Organism culture apparatus using pressure container
US5216901A (en) * 1989-02-08 1993-06-08 Gunze Kabushiki Kaisha Compound needle for knitting machines
US5316905A (en) * 1986-09-29 1994-05-31 Suzuki Shokan Co., Ltd. Culture medium supplying method and culture system
CN110678543A (en) * 2017-04-05 2020-01-10 耶达研究及发展有限公司 In vitro culture system and method of use

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316905A (en) * 1986-09-29 1994-05-31 Suzuki Shokan Co., Ltd. Culture medium supplying method and culture system
JPS63226204A (en) * 1987-03-17 1988-09-20 海洋科学技術センタ− Organism culture apparatus using pressure container
US5216901A (en) * 1989-02-08 1993-06-08 Gunze Kabushiki Kaisha Compound needle for knitting machines
CN110678543A (en) * 2017-04-05 2020-01-10 耶达研究及发展有限公司 In vitro culture system and method of use
JP2020516243A (en) * 2017-04-05 2020-06-11 イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. Ex vivo culture system and method of using the same
JP2023022119A (en) * 2017-04-05 2023-02-14 イェダ リサーチ アンド ディベロップメント カンパニー リミテッド Ex-vivo culture system and methods of using the same
US11920162B2 (en) 2017-04-05 2024-03-05 Yeda Research And Development Co. Ltd. Ex-vivo culture system and methods of using same
CN110678543B (en) * 2017-04-05 2024-04-09 耶达研究及发展有限公司 In vitro culture system and method of using the same

Similar Documents

Publication Publication Date Title
JP7075446B2 (en) Lung bioreactor
Gerlach et al. Bioreactor for a larger scale hepatocyte in vitro perfusion
US4225671A (en) Process for the in-vitro biosynthesis of hormones, especially insulin
AU668922B2 (en) Device for cell culture treatment
JP6463275B2 (en) Human and large mammalian lung bioreactors
US20040132175A1 (en) Cell culture chamber and bioreactor for extracorporeal culture of animal cells
Gerlach et al. Hepatocyte culture between three dimensionally arranged biomatrix-coated independent artificial capillary systems and sinusoidal endothelial cell co-culture compartments
US20100093066A1 (en) Decellularization and recellularization apparatuses and systems containing the same
WO1992007615A1 (en) A bioartificial liver
Calle et al. Procedure for lung engineering
CA2386001A1 (en) Method and apparatus for culturing cells
Yoshimoto et al. The role of cerebral microvessel endothelium in regulation of cerebral blood flow through production of endothelin-1
CN114672451A (en) Regeneration of functional pulmonary vascular beds
Aiken et al. Studies in rat liver perfusion for optimal harvest of hepatocytes
JPS6158582A (en) Continuous circulation cell culture apparatus
CN104379726A (en) bioartificial filter organ
US20090233361A1 (en) Tissue bioreactor
Rifkin et al. Plasminogen/plasminogen activator and growth factor activation
CN120399883A (en) Device and method for gradually adjusting the glucose concentration of in vitro embryo culture medium
Gerlach et al. Culture model for primary hepatocytes
JP2008271915A (en) Medium supply system for closed cell culture
RU2626526C1 (en) System of animal and human tissue bio-engineering models creation
Catapano et al. Combined effect of oxygen and ammonia on the kinetics of ammonia elimination and oxygen consumption of adherent rat liver cells
US20250034529A1 (en) Methods and Uses of Differentiated Cells
Rounds et al. The binding of cationic probes to apical and basal surfaces of rat lung capillary endothelium and of endothelial cells in tissue culture